Occurrence and Effects on Weaning From Mechanical Ventilation of Intensive Care Unit Acquired and Diaphragm Weakness:

Michele Bertoni1, Simone Piva1,2, Alessandra Beretta1

  • 1Department of Anesthesia, Critical Care and Emergency, Spedali Civili University Hospital, Brescia, Italy.

Frontiers in Medicine
|August 8, 2022
PubMed

Insights

Intensive care unit-acquired weakness (ICUAW) and diaphragm weakness (DW) frequently coexist in mechanically ventilated patients. ICUAW, not DW, significantly impacts ventilator-free days and weaning success.

Area of Science:

  • Critical Care Medicine
  • Neurology
  • Pulmonology

Background:

  • Mechanically ventilated (MV) patients often develop intensive care unit-acquired weakness (ICUAW) and diaphragm weakness (DW).
  • The coexistence and impact of ICUAW and DW, particularly in cooperative versus uncooperative patients, remain unclear.

Purpose of the Study:

  • To describe the co-occurrence of ICUAW and DW in MV patients.
  • To evaluate the impact of ICUAW and DW on ventilator-free days (VFDs) and weaning success.
  • To assess the correlation between maximal inspiratory pressure (MIP) and thickening fraction (TFdi) in patients with DW.

Main Methods:

  • A prospective pilot study involving 73 critically ill MV patients.
  • Muscle weakness assessed using the Medical Research Council score or simplified peroneal nerve test.
  • Diaphragm dysfunction defined by MIP < 30 cm H2O or TFdi < 29%; weaning success defined by the WIND criteria.

Main Results:

  • High prevalence of ICUAW (78%) and DW (81%) was observed, with co-occurrence in 65% of patients.
  • ICUAW, but not DW, was independently associated with reduced VFDs at 28 days and lower likelihood of successful weaning (WIND).
  • A significant but weak correlation was found between MIP and TFdi.

Conclusions:

  • ICUAW and DW frequently coexist in MV patients, without a significant association between the two conditions.
  • ICUAW is a significant predictor of prolonged ventilation and weaning failure, while DW is not.
  • Larger studies are needed to confirm findings and explore advanced diagnostic methods for DW.
Abstract

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
301
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
336
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
211
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
452
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
247
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
298